These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 27387960)

  • 1. Glucose and Palmitate Differentially Regulate PFKFB3/iPFK2 and Inflammatory Responses in Mouse Intestinal Epithelial Cells.
    Botchlett R; Li H; Guo X; Qi T; Zhao J; Zheng J; Woo SL; Pei Y; Liu M; Hu X; Chen G; Guo T; Yang S; Li Q; Xiao X; Huo Y; Wu C
    Sci Rep; 2016 Jul; 6():28963. PubMed ID: 27387960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disruption of inducible 6-phosphofructo-2-kinase impairs the suppressive effect of PPARγ activation on diet-induced intestine inflammatory response.
    Guo X; Li H; Xu H; Halim V; Thomas LN; Woo SL; Huo Y; Chen YE; Sturino JM; Wu C
    J Nutr Biochem; 2013 May; 24(5):770-5. PubMed ID: 22841546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adipose tissue inflammation and systemic insulin resistance in mice with diet-induced obesity is possibly associated with disruption of PFKFB3 in hematopoietic cells.
    Zhu B; Guo X; Xu H; Jiang B; Li H; Wang Y; Yin Q; Zhou T; Cai JJ; Glaser S; Meng F; Francis H; Alpini G; Wu C
    Lab Invest; 2021 Mar; 101(3):328-340. PubMed ID: 33462362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of inducible 6-phosphofructo-2-kinase in the anti-diabetic effect of peroxisome proliferator-activated receptor gamma activation in mice.
    Guo X; Xu K; Zhang J; Li H; Zhang W; Wang H; Lange AJ; Chen YE; Huo Y; Wu C
    J Biol Chem; 2010 Jul; 285(31):23711-20. PubMed ID: 20498376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disruption of inducible 6-phosphofructo-2-kinase ameliorates diet-induced adiposity but exacerbates systemic insulin resistance and adipose tissue inflammatory response.
    Huo Y; Guo X; Li H; Wang H; Zhang W; Wang Y; Zhou H; Gao Z; Telang S; Chesney J; Chen YE; Ye J; Chapkin RS; Wu C
    J Biol Chem; 2010 Feb; 285(6):3713-3721. PubMed ID: 19948719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted overexpression of inducible 6-phosphofructo-2-kinase in adipose tissue increases fat deposition but protects against diet-induced insulin resistance and inflammatory responses.
    Huo Y; Guo X; Li H; Xu H; Halim V; Zhang W; Wang H; Fan YY; Ong KT; Woo SL; Chapkin RS; Mashek DG; Chen Y; Dong H; Lu F; Wei L; Wu C
    J Biol Chem; 2012 Jun; 287(25):21492-500. PubMed ID: 22556414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adipocyte inducible 6-phosphofructo-2-kinase suppresses adipose tissue inflammation and promotes macrophage anti-inflammatory activation.
    Xu H; Zhu B; Li H; Jiang B; Wang Y; Yin Q; Cai J; Glaser S; Francis H; Alpini G; Wu C
    J Nutr Biochem; 2021 Sep; 95():108764. PubMed ID: 33964465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disruption of endothelial Pfkfb3 ameliorates diet-induced murine insulin resistance.
    Yang Q; Xu J; Ma Q; Liu Z; Zhou Y; Cai Y; Mao X; Stepp D; Weintraub N; Fulton DJ; Hong M; Huo Y
    J Endocrinol; 2021 Jul; 250(3):93-104. PubMed ID: 34101614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A role for inducible 6-phosphofructo-2-kinase in the control of neuronal glycolysis.
    Li H; Guo X; Xu H; Woo SL; Halim V; Morgan C; Wu C
    J Nutr Biochem; 2013 Jun; 24(6):1153-8. PubMed ID: 23246158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of 6-phosphofructo-2-kinase (PFKFB3) suppresses glucose metabolism and the growth of HER2+ breast cancer.
    O'Neal J; Clem A; Reynolds L; Dougherty S; Imbert-Fernandez Y; Telang S; Chesney J; Clem BF
    Breast Cancer Res Treat; 2016 Nov; 160(1):29-40. PubMed ID: 27613609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A role for
    Qi T; Chen Y; Li H; Pei Y; Woo SL; Guo X; Zhao J; Qian X; Awika J; Huo Y; Wu C
    J Mol Endocrinol; 2017 Jul; 59(1):49-59. PubMed ID: 28559290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adoptive transfer of
    Guo X; Zhu B; Xu H; Li H; Jiang B; Wang Y; Zheng B; Glaser S; Alpini G; Wu C
    Liver Res; 2020 Sep; 4(3):136-144. PubMed ID: 34336366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Laminar shear stress inhibits endothelial cell metabolism via KLF2-mediated repression of PFKFB3.
    Doddaballapur A; Michalik KM; Manavski Y; Lucas T; Houtkooper RH; You X; Chen W; Zeiher AM; Potente M; Dimmeler S; Boon RA
    Arterioscler Thromb Vasc Biol; 2015 Jan; 35(1):137-45. PubMed ID: 25359860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 6-phosphofructo-2-kinase/fructose 2,6-bisphosphatase-3 is required for transforming growth factor β1-enhanced invasion of Panc1 cells in vitro.
    Yalcin A; Solakoglu TH; Ozcan SC; Guzel S; Peker S; Celikler S; Balaban BD; Sevinc E; Gurpinar Y; Chesney JA
    Biochem Biophys Res Commun; 2017 Mar; 484(3):687-693. PubMed ID: 28161638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estradiol stimulates glucose metabolism via 6-phosphofructo-2-kinase (PFKFB3).
    Imbert-Fernandez Y; Clem BF; O'Neal J; Kerr DA; Spaulding R; Lanceta L; Clem AL; Telang S; Chesney J
    J Biol Chem; 2014 Mar; 289(13):9440-8. PubMed ID: 24515104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of inducible 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase/PFKFB3 isoforms in adipocytes and their potential role in glycolytic regulation.
    Atsumi T; Nishio T; Niwa H; Takeuchi J; Bando H; Shimizu C; Yoshioka N; Bucala R; Koike T
    Diabetes; 2005 Dec; 54(12):3349-57. PubMed ID: 16306349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-106a-5p targets PFKFB3 and improves sepsis through regulating macrophage pyroptosis and inflammatory response.
    Chen Y; Zhang P; Han F; Zhou Y; Wei J; Wang C; Song M; Lin S; Xu Y; Chen X
    J Biol Chem; 2024 Jun; 300(6):107334. PubMed ID: 38705396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PFKFB3-mediated glycolysis is involved in reactive astrocyte proliferation after oxygen-glucose deprivation/reperfusion and is regulated by Cdh1.
    Lv Y; Zhang B; Zhai C; Qiu J; Zhang Y; Yao W; Zhang C
    Neurochem Int; 2015 Dec; 91():26-33. PubMed ID: 26498254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TGF-β1 targets Smad, p38 MAPK, and PI3K/Akt signaling pathways to induce PFKFB3 gene expression and glycolysis in glioblastoma cells.
    Rodríguez-García A; Samsó P; Fontova P; Simon-Molas H; Manzano A; Castaño E; Rosa JL; Martinez-Outshoorn U; Ventura F; Navarro-Sabaté À; Bartrons R
    FEBS J; 2017 Oct; 284(20):3437-3454. PubMed ID: 28834297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphorylation of the 6-phosphofructo-2-kinase/fructose 2,6-bisphosphatase/PFKFB3 family of glycolytic regulators in human cancer.
    Bando H; Atsumi T; Nishio T; Niwa H; Mishima S; Shimizu C; Yoshioka N; Bucala R; Koike T
    Clin Cancer Res; 2005 Aug; 11(16):5784-92. PubMed ID: 16115917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.